KA
DRIO icon

Klingman & Associates’s DarioHealth DRIO Stock Holding History

Klingman & Associates’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-893
Closed -$12K – 324
2025
Q2 		$12K Hold
893
– – ﹤0.01% 314
2025
Q1 		$10.9K Hold
893
– – ﹤0.01% 263
2024
Q4 		$14K Hold
893
– – ﹤0.01% 256
2024
Q3 		$20K Hold
893
– – ﹤0.01% 265
2024
Q2 		$21.2K Hold
893
– – ﹤0.01% 250
2024
Q1 		$27.3K Hold
893
– – ﹤0.01% 238
2023
Q4 		$30.7K Hold
893
– – ﹤0.01% 225
2023
Q3 		$58.5K Hold
893
– – ﹤0.01% 219
2023
Q2 		$71.6K Hold
893
– – 0.01% 215
2023
Q1 		$73.5K Hold
893
– – 0.01% 198
2022
Q4 		$76.4K Buy
893
+161
+22% +$14.5K 0.01% 203
2022
Q3 		$68K Hold
732
– – 0.01% 187
2022
Q2 		$90K Hold
732
– – 0.01% 192
2022
Q1 		$86K Buy
+732
New +$121K 0.01% 203

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return

Klingman & Associates's DRIO Position: Q3 2025 in Review

Klingman & Associates sold out of DarioHealth (DRIO) in Q3 2025, closing a stake of 893 shares — an estimated $12K sold.

Klingman & Associates first reported a position in DRIO in Q1 2022 and held it in 14 quarters. The position peaked at $90K in Q2 2022. 23 funds tracked by Wall St. Rank hold DRIO as of Q3 2025.

  • Klingman & Associates reported no remaining DarioHealth position as of Q3 2025 after selling out during the quarter.
  • Klingman & Associates sold 893 DarioHealth shares in Q3 2025, an estimated $12K.
  • Klingman & Associates first reported a position in DarioHealth in Q1 2022 and held it in 14 quarters.
  • Klingman & Associates's DarioHealth position peaked at $90K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held DarioHealth as of Q3 2025.

Based on Klingman & Associates's 13F filing for Q3 2025, filed 27 Oct 2025.